Clinical Trial Update: Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing everolimus versus sirolimus in combination with calcineurin inhibitors for kidney transplant patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Everolimus (everolimus)
• Sirolimus (Sirolimus)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Kidney Transplantation | Phase 4 | Status: WITHDRAWN